Michigan Med University of Michigan — Ann Arbor, Michigan

Michigan Med University of Michigan is a clinical research site located in Ann Arbor, Michigan, United States 48109 5271.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Michigan Med University of Michigan has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Chronic Myelogenous Leukemia - Chronic Phase, Scleroderma, Diffuse, Follicular Lymphoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan Med University of Michigan?

Michigan Med University of Michigan has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan Med University of Michigan conducted?

Michigan Med University of Michigan has 4 clinical trials on record, with 2 currently active. Their work covers Chronic Myelogenous Leukemia - Chronic Phase, Scleroderma, Diffuse, Follicular Lymphoma.

Is Michigan Med University of Michigan accredited by Crixeo Health?

Michigan Med University of Michigan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michigan Med University of Michigan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.